Clinical Trial

YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies

Name: YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies — clinical trial record (NCT07763301)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study aims to determine the safety and maximum tolerated dose (MTD) of YMN-136 vaccine through a dose escalation trial, and to investigate whether YMN-136 vaccine can assist in the treatment of patients with advanced hepatobiliary and pancreatic malignancies.

Trial Details

NCT Number	NCT07763301
Lead Sponsor	West China Hospital
Conditions	Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)
Enrollment	9 participants
Start Date	2026-08-01
Primary Completion	2028-02-29 (estimated)
Study Completion	2028-05-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-13